Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing

SIMPLE SUMMARY: Despite improvements in standardized screening methods and the development of promising therapies for colorectal cancer (CRC), survival rates are still low. Drug repurposing offers an affordable solution to achieve new indications for previously approved drugs that could play a prota...

Descripción completa

Detalles Bibliográficos
Autores principales: El Zarif, Talal, Yibirin, Marcel, De Oliveira-Gomes, Diana, Machaalani, Marc, Nawfal, Rashad, Bittar, Gianfranco, Bahmad, Hisham F., Bitar, Nizar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099737/
https://www.ncbi.nlm.nih.gov/pubmed/35565237
http://dx.doi.org/10.3390/cancers14092105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099737/
https://www.ncbi.nlm.nih.gov/pubmed/35565237
http://dx.doi.org/10.3390/cancers14092105

Ejemplares similares